// App-Quantinova.ai

2101 : A gene-expression fingerprint predicting sensitivity to all-trans-retinoic acid in breast cancer cells is tumor-context independent

Researchers

Presenter

  • Enrico Garattini

Principal Investigators

  • Maurizio Gianni

  • Marco Bolis

  • Maddalena Fratelli

  • Gabriela Paroni

  • Mineko Terao

Medical Centers

  • Mario Negri Inst. for Pharmacol. Research, Milan, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute promyelocytic leukemia

  • Acute myelocytic leukemia

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Promyelocytic Leukemia

Drug/Treatment

  • Tretinoin

  • Tigason

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved